Skip to main content

The treatment of bipolar depression

Author/s
Jenny Hopwood, Mark Agius
Citation
Issue 3 Summer 2013
CEPiP.2013;1:209-211
Abstract

The treatment of bipolar disorder, including management of mania and depression in primary and secondary care, is well described in the NICE guidance on this subject1.. This article summarises and updates the guidance on the treatment of bipolar depression, describing the use of mood stabilisers in combination with antidepressants as well as the use of quetiapine and lamotrigine and thus provides practical advice on how bipolar depression can be managed in primary care.

Keywords: bipolar disorder, bipolar depression, treatment, primary care, NICE

Cite as: Cutting Edge Psychiatry in Practice 2013, 3(1):209-211; https://doi.org/10.65031/ihqr7559

References

  1. NICE Guidance CG38: Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care  
  2. Hirschfeld et al. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003 Feb;64 (2):161-74 https://doi.org/10.4088/jcp.v64n0209
  3. Ghaemi et al. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999 Jan-Mar;52 (1-3):135-44. https://doi.org/10.1016/s0165-0327(98)00076-7
  4. Ghaemi et al. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry. 2004 Jan;161 (1):163-5.     
  5. Post et al. Treatment of bipolar depression. CNS Spectr. 2003 Dec;8 (12):1-10; quiz 11.    
  6. Nolen WA & Bloemkolk D. Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm. Neuropsychobiology. 2000;42 Suppl 1:11-7. https://doi.org/10.1159/000054845
  7. Calabrese et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 1999 Feb;60 (2):79-88. https://doi.org/10.4088/jcp.v60n0203
  8. Gao et al. Typical and atypical antipsychotics in bipolar depression. J Clin Psychiatry. 2005 Nov;66 (11):1376-85. https://doi.org/10.4088/jcp.v66n1106
  9. Post et al. Bipolar depression: the role of atypical antipsychotics. Expert Rev Neurother. 2004 Nov;4 (6 Suppl 2):S27-33.     
  10. Weisler et al. Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies. J Clin Psychiatry. 2008 May;69 (5):769-82. https://doi.org/10.4088/jcp.v69n0510
  11. Thase et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006 Dec;26 (6):600-9. Erratum in: J Clin Psychopharmacol. 2007 Feb;27 (1):51. https://doi.org/10.1097/01.jcp.0000248603.76231.b7